Trulieve Cannabis Corp.

US$11.56As of Sun 8 Nov 2026, 12:00 UTC
NYSE:TRLVHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (0.12%)
Div yield —
ROE (45.58%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.92
PE TTM —
TSR TTM 59.45%
Mkt cap US$2.226B
ROIC 12.92%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$13
13.56%
(3.67%)
Hold 9|11|5|0|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.13
0.13
0.12
0.14
4.82%
7.91%
6.83%
14.62%
Revenue$M
296.9
289.0
304.2
319.8
8.01%
0.45%
7.07%
13.97%
Peers (US$2.226B)
Cap (US$)
PE
2.777B
—
2.037B
13.23x
Capital
TTM
5Y
10Y
Leveragex
0.922
(0.526)
(0.531)
EBIT/Intx
1.062
0.786
0.754
Own earn%
71.66
18.81
24.42
Sh yield%
44.59
34.84
35.90
Owners
Insiders/Inst%
4.28
21.83
Short interest%
2.77
SBC / revenue%
3.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
16–23
$1 testx
—
Incr. ROIC%
2